Diabetes Case Study: A New Perspective on Type 1 and Type 2

Home

Get Involved

Update

Thank you

Letters

Diabetes Research

Links and References

Whole Grains

Tell your diabetes story

Preface

Introduction

The Cause of Diabetes

Cause of Hyperglycemia

Insulin

The Word Game

The C-Peptide Test

Interpreting C-Peptide

Bacteria

Antibiotics

Fever

My Life before Diabetes

My Life with Diabetes Now

The Evidence

Original Diagnosis

C-Peptide Test Result

Graph

Key

Thyroid Tests

My Diabetic Food Pyramid

Contact information

Image: 
I had the honor of meeting Dr. Kirt Tyson on Nov. 9, 2013 at a student Discovery Day event at the Southwest College of Naturopathic Medicine in Tempe, AZ. Dr. Tyson was diagnosed with type 1 diabetes (GAD positive, low c-peptide, and blood glucose over 300 at time of C-peptide test) in 2005, he is a 2011 graduate of SCNM and he shares how he was able to reverse his diabetes in his book available from Amazon.
 
Media
Paul Tubiana on the radio
Document
Paul Tubiana investigates how his diabetes was misdiagnosed as a child, because doctors failed to perform a C-Peptide Test. His breakthrough analysis uncovers startling connections between nutrition, infections, and diabetes -- important information for anyone affected by diabetes today.


facebook fan page
twitter follow
Cure Type 1 Diabetes Support C-Peptide Testing for Diabetic Children
D i a b e t e s
 
Case Study

 

* * *

A New Perspective on Type 1 and Type 2

 
 
By Paul J.Tubiana
http://www.diabetescasestudy.com

Disclaimer: The statements presented in this document are intended for informative purposes only.  These statements have not been evaluated by any third party, public or private.  The statements contained herein are solely the opinions of the author, and are not intended to diagnose, treat, or cure any condition, symptom, or ailment, nor to suggest nor prescribe any course of action.  The author expressly does not accept or assume any responsibility or liability for its use, misuse, or interpretation and/or any consequences or damages.  It is the reader's responsibility to seek his or her own professional medical advice and to do the research that may confirm or deny the validity of this presentation.  The author expressly does not endorse any product, service, or method.  The following brand names wherever they may appear in this document are registered trademarks of their respective companies and/or affiliates and/or partnerships and/or holding companies and/or licensors and/or assignees, to the author’s best knowledge as follow:  Humulin® R insulin, Humulin® N insulin, and Humalog® insulin are registered trademarks of Eli Lilly and Company, Indianapolis, IN USA; Lantus® insulin is a registered trademark of Aventis Pharma Deutschland GmbH, and/ or Hoechst AG, Frankfurt am Main, Germany, and/or its related affiliates;  NovoLog® is a registered trademark of NovoNordisk A/S, Bagsvaerd, Denmark;  Glucophage® XR is a registered trademark of Lyonnaise Industrielle Pharmaceutique, s.a. (LIPHA, s.a.), Lyon, France and is licensed to Bristol-Myers Squibb Company, Princeton, NJ USA; Zithromax® is a registered trademark of Pfizer, Inc. USA;  Augmentin®  1000 XR is a registered trademark of SmithKline Beecham Corp., Philadelphia, PA  USA ; Synthroid® is a registered trademark of Abbott Laboratories Corp., Abbott Park, IL USA and/or Knoll Pharmaceutical Corp., Mount Olive, NJ USA and/or Travenol Laboratories, Inc., Morton Grove, IL USA; Quest Diagnostics® is a registered  trademark of Quest Diagnostics Incorporated.


Website Copyright 2003-2013 Paul J. Tubiana                All rights reserved. 
This document may not be reproduced or translated in whole or in part by any means, and may not be sold, distributed, downloaded, otherwise transferred, or used to endorse a product or service without express written permission.